Synthesis and structure of highly substituted pyrazole ligands and their complexes with platinum(II) and palladium(II) metal ions

Reaction of 3-methoxycarbonyl-2-methyl- or 3-dimethoxyphosphoryl-2-methyl-substituted 4-oxo-4H-chromones 1 with N-methylhydrazine resulted in the formation of isomeric, highly substituted pyrazoles 4 (major products) and 5 (minor products). Intramolecular transesterification of 4 and 5 under basic conditions led, respectively, to tricyclic derivatives 7 and 8. The structures of pyrazoles 4a (dimethyl 2-methyl-4-oxo-4H-chromen-3-yl-phosphonate) and 4b (methyl 4-oxo-2-methyl-4H-chromene-3-carboxylate) were confirmed by X-ray crystallography. Pyrazoles 4a and 4b were used as ligands (L) in the formation of ML₂Cl₂ complexes with platinum(II) or palladium(II) metal ions (M). Potassium tetrachloroplatinate(II), used as the metal ion reagent, gave both trans-[Pt(4a)₂Cl₂] and cis-[Pt(4a)₂Cl₂], complexes with ligand 4a, and only cis-[Pt(4b)₂Cl₂] isomer with ligand 4b. Palladium complexes were obtained by the reaction of bis(benzonitrile)dichloropalladium(II) with the test ligands. trans-[Pd(4a)₂Cl₂] and trans-[Pd(4b)₂Cl₂] were the exclusive products of these reactions. The structures of all the complexes were confirmed by IR, ¹H NMR and FAB MS spectral analysis, elemental analysis and Kurnakov tests.     

Novel phthalocyanines bearing four 4-phenyloxyacetic acid functionalities

Metal-free (2) and Co(II), Zn(II), Ni(II), Cu(II) metallophthalocyanines (2a–d) with four 4-phenyloxyacetic acid groups on the periphery were prepared by cyclotetramerization of new p-(3,4-dicyanophenoxy)phenylacetic acid (1) and the corresponding divalent metal salts. Further reactions of these products with thionylchloride and then benzylamine in tetrahydrofuran, and octanol in pyridine gave amide (3, 3a–d) and ester (4, 4a–d) derivatives, respectively. The new compounds have been characterized by elemental analyses, IR, UV–Vis, mass and ¹H NMR spectroscopy. The redox properties of compounds 2 and 2a–d were identified by cyclic voltammetry.     

The synthesis, spectroscopic properties and X-ray structure of Zn(II) complexes with amino derivatives of chromone

Three new Zn(II) complexes containing the ligands 5-amino-8-methyl-4H-chromen-4-one (1), 6- or 7-amino-2-phenyl-4H-chromen-4-one (2, 3) were prepared. The new synthesised compounds were characterised by IR, ¹H NMR and MS spectroscopy. The crystal structure of complex 4 was determined with the use X-ray diffraction. The Zn(II) centre of 4 is linked by two chlorido and two N-bound aminochromone ligands, 1, in a strongly distorted tetrahedral configuration with the dissymetric point group C₂. The protonation constants of the ligands 1, 2 and 3 corresponded to 3.68, 3.88 and 6.83, respectively. The stability constants of the Zn(II) complexes were calculated from the potentiometric titration data. The complexes were found to have the formulae ML and ML₂ for ligands 1 and 2, and ML for ligand 3. Fluorescence spectroscopic properties were also studied; the strongest fluorescence in solution was exhibited by complex 6.     

Formation of bis- and tris[2]catenanes via the cross-catenation of Pd(II)- and Pt(II)-linked coordination rings

We have demonstrated the self-assembly of linear oligo[2]catenanes via selective cross-catenation. A Pd(II)-linked double looped molecule 1 was transformed into the cyclic trimer c-(1)₃ through the catenation. When 1 was treated with a kinetically inert Pt(II)-linked single looped molecule 2a in aqueous media (1:1.2 DMSO/H₂O) at room temperature, linear oligo[2]catenanes of 2a-(1)_n-2a (n=1 and 2) were selectively obtained, because the kinetically inert Pt(II)-linked ring 2a is allowed to thread on only kinetically labile Pd(II)-linked ring of 1. The distribution of the oligomers depends on the monomer ratio of 1 to 2a. When the ratio of 1 to 2a was 1:2, bis[2]catenane 3a (2a-1-2a) was quantitatively assembled. When the ratio of 1 to 2a was 1:1, not only 3a but also tris[2]catenane 4 (2a-1-1-2a) was assembled. The ratio of 3a to 4 was carefully determined to be 1:1 by NMR. The lengths of 3a and 4 in an extended conformation were estimated by MD/MM2 simulation to be 3.6 and 5.4 nm, respectively.     

cis-Palladium(II) complexes of derivatives of di-(2-pyridyl)methane: Study of the influence of the bridge group in the coordination mode

Palladium(II) complexes containing di-(2-pyridyl)-N-methylimine (1), di-(2-pyridyl)methanol (2) and di-(2-pyridyl)methyl-N,N-diethyldithiocarbamate (4) ligands were synthesized and characterized by ¹H and ¹³C NMR in solution, IR and X-ray single crystal diffraction. Crystal structures of cis-dichloro[di-(2-pyridyl)-N-methylimine]palladium(II) (5), cis-dichloro[di-(2-pyridyl)methanol]palladium(II) (6) and cis-dichloro[di-(2-pyridyl)methyl-N,N-diethyldithiocarbamate]palladium(II) (7) showed a bidentate coordination mode of the di-(2-pyridyl)methane derivatives 1, 2 and 4. In these complexes is observed the formation of a five-membered chelate ring with the iminic ligand 1 and six-membered chelate rings with the pyridinic ligands 2 and 4. In all complexes the palladium atom displays a distorted square planar geometry.     

Synthesis,characterization, crystal structures, in vitro and in vivo antitumor activity of palladium(II) and zinc(II) complexes with 2-formyl and 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone

The present paper includes synthesis and spectral characterization of the novel prepared palladium(II) and zinc(II) complexes with 2-formyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone, HFo4Npypipe, 1 and the 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone, HAc4Npypipe, 2. The Pd(II) complexes [PdCl(Fo4Npypipe)], 3, [PdCl(Ac4Npypipe)], 4 and the Zn(II) complexes [ZnCl₂(Fo4Npypipe)], 5 and [ZnCl₂(Ac4Npypipe)], 6 have been characterized by elemental analyses and spectroscopic studies. The crystal structure of the complexes [PdCl(Fo4Npippy)], 3 and [PdCl(Ac4Npippy)], 4, have been solved by single-crystal X-ray diffraction. The electronic, IR, UV/Vis, and NMR spectroscopic data of the complexes are reported. The results of the cytotoxic activity of 1–6 have been evaluated in vitro against the cells of three human cancer cell lines: MCF-7, T24, A-549 and a mouse L-929 (a fibroblast-like cell line cloned from strain L). For selected compounds 2 and 6 the acute toxicity and antitumor activity were evaluated on leukemia P388-bearing mice. The Zn(II) compounds 5 and 6 are considered as agents with potential antitumor activity, and can therefore be candidates for further stages of screening in vitro and/or in vivo.     

Simple preparation of phenylpropenoid β-d-glucopyranoside congeners by Mizoroki-Heck type reaction using organoboron reagents

Palladium(II)-catalyzed carbon-carbon bond formation between allyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyranoside (3) and arylboronic acid congeners gave the corresponding cinnamyl 2,3,4,6-tetra-O-acetyl- β-d-glucopyranosides (4a-m) in good yield. Among them, coupling products 4a-m were converted to not only the naturally occurring phenylpropenoid β-d-glucopyranoside analogues (1a-e) but also the unnaturally ones (1f-m).     

Simple synthesis of phenylpropenoid β-d-glucopyranoside congeners based on Mizoroki-Heck type reaction of organoboron reagents

Palladium(II)-catalyzed carbon-carbon bond formation between allyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyranoside (3) and phenylboronic acid congeners gave the phenylpropenoid 2,3,4,6-tetra-O-acetyl-β-d-glucopyranoside (4a-f) in good yield. Among them, compounds 4a-c were converted to the naturally occurring phenylpropenoid β-d-glucopyranoside analogues (1a-c).     

Ruthenium(II)-CO complexes of N-[(2-pyridyl)methyliden]-α(or β)-aminonaphthalene: Synthesis, spectral studies, crystal structure, redox properties and DFT calculation

The characterization and properties of trans-(X)-[RuX₂(CO)₂(α/β-NaiPy)] (1, 2) (α-NaiPy (a), β-NaiPy (b); X = Cl (1), I (2)) are described in this work. The structures are confirmed by single crystal X-ray diffraction studies. Reaction of these compounds with Me₃NO in MeCN has isolated monocarbonyl trans-(X)-[RuX₂(CO)(MeCN)(α/β-NaiPy)] (3, 4). The complexes show intense emission properties. Quantum yields of 1 and 2 (? = 0.02-0.08) are higher than 3 and 4 (? = 0.006-0.015). Voltammogram shows higher Ru(III)/Ru(II) (1.3-1.5 V) potential of 1 and 2 than that of 3 and 4 (0.8-0.9 V) that may be due to coordination of two π-acidic CO groups in former. The electronic spectra and redox properties of the complexes are compared with the results obtained by density functional theory (DFT) and time-dependent density functional theory (TD-DFT) using polarizable continuum model (CPCM).     

Synthesis of 6-substituted tetrahydropyridinones and cyclization to indolizidine and quinolizidine structures

3-Sulfolenes 1 with various substituents at C-2 underwent [4+2] cycloaddition reactions with p-toluenesulfonyl isocyanate to give the teterahydropyridinones 4. Through N-detosylation and Hg(II)-mediated electrophilic addition/intramolecular cyclization of 4e and 4f, the indolizidine and quinolizidine compounds 7a/7b and 8 were synthesized, respectively.     

Synthesis and X-ray structure of platinum(II), palladium(II) and copper(II) complexes with pyridine–pyrazole ligands: Influence of ligands’ structure on cytotoxic activity

The new pyrazole ligand 5-(2-hydroxyphenyl)-3-methyl-1-(2-pyridylo)-1H-pyrazole-4-phosphonic acid dimethyl ester (2a) has been used to obtain a series of platinum(II), palladium(II) and copper(II) complexes (3a–7a) as potential anticancer compounds. The molecular structures of the platinum(II) and copper(II) complexes 3a and 6a have been determined by X-ray crystallography. The cytotoxicity of the phosphonic ligand 2a and its carboxylic analog 2b as well as their complexes has been evaluated on leukemia and melanoma cell lines. Copper(II) complexes were found to be more efficient in the induction of melanoma cell death than the platinum(II) or palladium(II) complexes. Cytotoxic effectiveness of compound 7b against melanoma WM-115 cells was two times better than that of cisplatin. The reaction of compound 5b with 9-methylguanine has been studied.     

Copper-mediated coupling of aminopurines and aminopyrimidines with arylboronic acids

Selective N-arylation of aminopurines and aminopyrimidines 1-3 with arylboronic acids 4-6 was explored using copper(II) acetate and the corresponding N-arylated purine and pyrimidine derivatives 7-15 were obtained in moderate to good yields.     

9,21,22-Triaza-2,11-dithia[3.3](2,6)pyridino(2,9)phenanthrolinophane: a five-donor macrocycle functioning as a bidentate ligand

9,21,22-Triaza-2,11-dithia[3.3](2,6)pyridino(2,9)phenanthrolinophane 4 was prepared from a cyclization reaction of 2,6-bis(mercaptomethyl)pyridine 5 and 2,9-bis(bromomethyl)phenanthroline 6. Results from ¹H NMR analysis are inconclusive but those derived from semi-empirical molecular orbital PM3 calculations support a preference for a syn conformation for 4. The conformation barrier for interconversion between two syn isomers of 4 was estimated to be 36.5 kJ mol⁻¹ on the basis of a dynamic ¹H NMR study. The manganese(II) and zinc(II) complexes of 4 were prepared and the metal to ligand ratios were found to be 1:1 and 2:1, respectively, by elemental analyses. Results from an ¹H NMR analysis of the zinc(II) complex of 4 suggest that only the two nitrogen atoms of the phenanthroline moiety participate in the co-ordination.     

Catenar bimetallomesogens derived from quinoxaline–salicylaldimine conjugates

The preparation, characterization, and mesomorphic properties of two series of tridentate N-salicylidene-2-hydroxyanilines and their metal complexes were described. The crystal and molecular structure of bis[2-hydroxy-4-propyloxy-N-(2-hydroxy-3,4-dipropyloxybenzylidene) aniline]copper(II) were determined by means of X-ray analysis. It crystallizes in the monoclinic space group P2(1)/n and a Z=4. The geometry at Cu²⁺ ions is square pyramidal with a THF solvent molecule coordinated. The core structure was nearly flat, and the intramolecular Cu–Cu atoms were separated by ca. 3.0163(6) Å. All compounds 2a formed smectic C phases, and copper complexes 1a–Cu were not mesogenic. In contrast, compound 2e and complexes 1b–Cu, 1d–Cu, 1e–Cu, and 1e–Pd exhibited columnar phases. The lack of mesomorphism in 1e–Zn was attributed to a preferred tetrahedral over square planar geometry. A N_cell equal to 2.44–2.92, calculated from powder XRD data within a 9.0 Å thick indicated that an induced structure correlated by two catenar-shaped molecules was formed in Col_h phases.     

Five-membered ring chelate complexes of Ni(II), Pd(II) and Pt(II) derived of di-(2-pyridyl)-N-ethylimine

Cis-diaquobis{di-(2-pyridyl)-N-ethylimine}nickel(II) chloride (2) was obtained from the reaction of di-(2-pyridyl)-N-ethylimine (1) and [NiCl₂dppe] [dppe = cis-1,2-bis(diphenylphosphino)ethylene] in a 2:1 ratio in hot acetonitrile. Cis-dichloro{di-(2-pyridyl)-N-ethylimine}palladium(II) (3) and cis-dichloro{di-(2-pyridyl)-N-ethylimine}platinum(II) (4) complexes were obtained from the reaction of MCl₂ (M = Pd, Pt) and (1) in equimolar ratio in hot acetonitrile. Compounds 1–4 were characterized by IR spectroscopy, elemental analysis, and mass spectrometry; the complexes 3 and 4 were characterized in solution by NMR. In addition, solid state structures of compounds 1–4 were determined using single crystal X-ray diffraction analyses. X-ray diffraction data of the complexes 3 and 4 showed a distorted square planar local geometry at palladium and platinum atoms with the chlorine atoms in a cis-coordination; in 2 a local octahedral geometry at nickel atom was observed. Complexes 3 and 4 are arranged as dimers with a M?M distance of 3.4567(4) Å (M = Pd) and 3.4221(4) Å (M = Pt), respectively; 2 consists of units linked by intermolecular hydrogen bonding.     

Syntheses of two diamine substituted 1,3-distal calix[4]arene-based magnetite nanoparticles for extraction of dichromate, arsenate and uranyl ions

The synthesis of two new calixarene derivatives 4 and 5, functionalized at the lower rim with 4-amino-1-benzylpiperidine to give diamide and diamine derivatives of p-tert-butylcalix[4]arene, is described. They were obtained by the reaction of both the diester derivative of p-tert-butylcalix[4]arene (2) and the dialkyl bromide derivative of p-tert-butylcalix[4]arene (3) with 4-amino-1-benzylpiperidine. The ¹H NMR spectra of calixarene derivatives show that 4 and 5 exist in the cone conformation. Moreover, these diamide and diamine derivatives of p-tert-butylcalix[4]arene (4 and 5) have been immobilized onto [3-(2,3-epoxypropoxy)-propyl]-trimethoxysilane-modified Fe₃O₄ magnetite nanoparticles to obtain calixarene-based magnetic nanoparticles M-DADBP-Calix (6) and M-DABP-Calix (7). The calix[4]arene immobilized materials were characterized by a combination of Fourier Transform Infrared Spectroscopy (FTIR), Transmission Electron Microscopy (TEM) and Thermogravimetric Analyses (TGA) and elemental analysis. Additionally, the studies regarding the removal of As(V)/Cr(VI) ions as well as U(VI) ion from aqueous solutions were also carried out by using these compounds in liquid-liquid/solid-liquid extraction experiments.     

Asymmetric Michael addition using N-cinnamoyl- and N-crotonyl-trans-hexahydrobenzoxazolidin-2-ones

Preparation of N-cinnamoyl- and N-crotonyl-oxazolidin-2-ones 2 and 3 or ent-2 and ent-3 from (4S,5S)- and (4R,5R)-trans-hexahydrobenzoxazolidin-2-ones 1 or ent-1 are reported. Stereoselective copper promoted conjugated additions of Grignard reagents to chiral N-enoyl amides 2 and 3 or ent-2 and ent-3 in the presence of Zn(II) salts afforded the 1,4-addition products 4-11 and the corresponding enantiomers.     

Synthesis, characterization, antibacterial and cytotoxic activity of new palladium(II) complexes with dithiocarbamate ligands: X-ray structure of bis(dibenzyl-1-S:S′-dithiocarbamato)Pd(II)

Six palladium(II) dithiocarbamates of general formula Pd(AmDTC)₂, where HAmDTC = aminedithiocarbamic acid, [Pd(II) piperidinedithiocarbamate (1), Pd(II) 4-methylpiperidinedithiocarbamate (2), Pd(II) N-methylbenzyldithiocarbamate (3), Pd(II) dibenzyldithiocarbamate (4), Pd(II) dicyclohexyldithiocarbamate (5), Pd(II) N-cyclohexyl-N-methyldithiocarbamate (6)] have been synthesized and characterized by elemental analyses, FT-IR, ¹H and ¹³C NMR. The X-ray structure of Pd(II), compounds 3 and 4, showed that the ligands are chelated by both sulfur atoms with bond angles S1-Pd-S4 = 179.24(2)° and S2-Pd-S3 = 179.09(5)°, with a distorted square planar geometry around Pd. All these complexes were screened for cytotoxic and antibacterial effects and showed significant antibacterial activity and no substantial in vitro cytotoxicity indicating specificity of the compounds.     

Novel megastigmanes with lipid accumulation inhibitory and lipid metabolism-promoting activities in HepG2 cells from Sedum sarmentosum

Four novel megastigmanes, neosedumosides I (1), II (2), III (3), and IV (4) were isolated from the whole plant of Sedum sarmentosum (Crassulaceae). Absolute stereostructures of these constituents were determined on the basis of chemical and physicochemical evidence. Among them, 1-3 were found to show lipid accumulation inhibitory activity in HepG2 cells. Furthermore, 2 and 3 were found to also show lipid metabolism-promoting activity.     

Synthesis of an octasubstituted galactose zinc(II) phthalocyanine

4,5-Bis(1,2:3,4-di-O-isopropylidene-α-d-galactopyranos-6-yl)phthalonitrile (3) was prepared by S_NAr reaction of diacetone galactose 1 and 4,5-difluorophthalonitrile (2) in 96% yield. Cyclotetramerization of 3 was achieved via its isoindoline derivative 4, affording the peripherally octasubstituted galactose zinc(II) phthalocyanine 5 in 29% yield. Deprotection of 5 gave the highly water soluble octasubstituted galactose zinc(II) phthalocyanine 6 in 81% yield which will be applied as a photosensitizer in photodynamic therapy.